1099 — Sinopharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapSuper Stock

Annual balance sheet for Sinopharm Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	39,192	50,217	43,541	55,327	63,809
Net Total Accounts Receivable
Net Total Receivables	126,563	149,448	176,273	175,733	185,790
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	230,000	267,610	290,922	319,406	336,835
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	18,063	18,896	19,408	19,647	19,898
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	269,888	311,237	335,412	364,775	383,395
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	178,425	203,977	219,307	234,963	241,491
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	222,466	254,878	273,526	296,707	308,813
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	47,422	56,359	61,886	68,069	74,582
Total Liabilities & Shareholders' Equity	269,888	311,237	335,412	364,775	383,395
Total Common Shares Outstanding